Maria L. Del Giudice
Pisa, 56126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Early Soluble B-Cell Maturation Antigen (BCMA/TNFRSF17) Kinetics as a Molecular Biomarker of Treatment Response in Multiple Myeloma Patients.
Journal: International journal of molecular sciences
Published: May 17, 2026
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.
Journal: British journal of haematology
Published: April 26, 2026
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM.
Journal: British journal of haematology
Published: September 02, 2025
How First-Line Therapy is Changing in Transplant-Eligible Multiple Myeloma Patients.
Journal: Mediterranean journal of hematology and infectious diseases
Published: January 31, 2025
Attenuation-based estimation of myocardial extracellular volume from ECG-ungated whole-body CT examinations as an early biomarker of chemotherapy-induced cardiotoxicity: preliminary findings.
Journal: La Radiologia medica
Published: January 09, 2025
Monoclonal Antibodies in Relapsed-Refractory Multiple Myeloma.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 13, 2024
Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients.
Journal: Haematologica
Published: December 11, 2024
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis.
Journal: European heart journal. Cardiovascular Imaging
Published: November 06, 2024
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.
Journal: HemaSphere
Published: July 31, 2024
Predictive Role of Soluble B-Cell Maturation Antigen in Short-Term Monitoring of Differently Treated Multiple Myeloma Patients: A Prospective Study.
Journal: Journal of clinical laboratory analysis
Published: July 29, 2024
Risk of SARS-CoV-2 infection and severe COVID-19 in hematological patients who received or not pre-exposure prophylaxis with tixagevimab/cilgavimab: a target trial emulation.
Journal: Leukemia & lymphoma
Published: June 04, 2024
Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy.
Journal: Annals of hematology
Published: May 10, 2024
Last Updated: 09/26/2026